Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Head And Neck Cancer (HNC) Industry Compare Between 2025 And 2029?
The market size for head and neck cancer (hnc) has demonstrated significant growth in recent years. This market is projected to expand from $2 billion in 2024 to $2.16 billion by 2025, reflecting a compound annual growth rate (CAGR) of 8.2%. Historically, this expansion has been driven by factors such as an increase in the incidence of HPV-related cancers, a rise in smoking and alcohol consumption, escalating investment in cancer research, improved awareness and early diagnosis initiatives, and the demographic shift towards an aging population.
The market size for head and neck cancer (hnc) is anticipated to expand significantly in the coming years. It is projected to reach $2.91 billion by 2029, driven by a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period can be attributed to factors such as broadening healthcare infrastructure, increasing patient demographics, a rising geriatric population, growing healthcare expenditures, and the continued prevalence of tobacco use and alcohol consumption. Dominant trends during this period are expected to include advancements in immunotherapy, the development of targeted therapies, greater technological integration, the incorporation of artificial intelligence (AI), and the adoption of precision medicine.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20825&type=smp
Which Major Market Drivers Are Shaping The Future Of The Head And Neck Cancer (HNC) Market?
The future expansion of the head and neck cancer (HNC) market is anticipated to be fueled by the rising frequency of cigarette smoking. Cigarette smoking involves breathing in and out smoke from burning tobacco in cigarettes, frequently linked to health dangers and dependence. This escalation in cigarette smoking is commonly influenced by elements such as stress, peer pressure, intensive promotional activities, and the availability of tobacco items. Medications for head and neck cancer aim to lessen the detrimental impacts of smoking by addressing molecular changes caused by smoking and treating cancers associated with tobacco consumption, concurrently highlighting the necessity to minimize exposure to carcinogens from smoking for improved treatment results. For example, in October 2024, the European Respiratory Society (ERS), a non-profit organization based in Switzerland, reported a study on smoking patterns among young individuals, indicating a notable increase in smoking rates, with 22.5% of surveyed individuals smoking in 2022 escalating to 40.1% in 2024. Consequently, the heightened occurrence of cigarette smoking is propelling the growth of the head and neck cancer (HNC) market.
What Are The Different Segment Classifications Within The Head And Neck Cancer (HNC) Market?
The head and neck cancer (hnc)market covered in this report is segmented –
1) By Type: Laryngeal Cancer, Pharyngeal Cancer, Salivary Gland Cancer, Lip And Oral Cavity Cancer, Nasopharyngeal Cancer, Other Types
2) By Treatment: Chemotherapy, Surgery, Radiation Therapy, Targeted Therapy, Other Treatments
3) By Diagnosis: Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, Endoscopy
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, E-commerce
5) By End User: Hospital, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Laryngeal Cancer: Supraglottic Laryngeal Cancer; Glottic Laryngeal Cancer; Subglottic Laryngeal Cancer
2) By Pharyngeal Cancer: Oropharyngeal Cancer; Nasopharyngeal Cancer; Hypopharyngeal Cancer
3) By Salivary Gland Cancer: Parotid Gland Cancer; Sublingual Gland Cancer; Submandibular Gland Cancer; Minor Salivary Gland Cancer
4) By Lip And Oral Cavity Cancer: Lip Cancer; Buccal Mucosa Cancer; Tongue Cancer; Gingival Cancer; Palate Cancer
5) By Nasopharyngeal Cancer: Early-Stage Nasopharyngeal Cancer; Advanced-Stage Nasopharyngeal Cancer
6) By Other Types: Thyroid Cancer; Esophageal Cancer; Sinonasal Cancer
Which Market Trends Are Creating New Opportunities In The Head And Neck Cancer (HNC) Industry?
Companies within the head and neck cancer (HNC) market are concentrating on developing advanced formulations, such as immune oncology drugs, to improve treatment effectiveness, enhance patient survival rates, and meet outstanding medical requirements in handling intricate and advanced-stage cancers. Immuno-oncology drugs are treatments that utilize the body’s immune system to detect and fight cancer cells. These therapies comprise checkpoint inhibitors, CAR-T cell therapies, and cancer vaccines. For example, in November 2024, Dr. Reddy’s Laboratories, an India-based pharmaceutical company, introduced toripalimab, an immune oncology drug for adults afflicted with a rare type of head and neck cancer originating in the nasopharynx, located in the upper part of the throat. This medication is purposed for managing recurrent or metastatic nasopharyngeal carcinoma. It will be sold under the brand name Zytorvi. The drug has exhibited a 48% reduction in the risk of progression or death when employed in conjunction with conventional chemotherapy (gemcitabine and cisplatin).
Who Are The Key Multinational Companies Dominating The Head And Neck Cancer (HNC) Market?
Major companies operating in the head and neck cancer (HNC) market are Pfizer Inc., Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer Healthcare AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Koninklijke Philips N.V., Boehringer Ingelheim, Fresenius Kabi AG, Incyte Corporation, Exelixis Inc., Astellas Pharma Inc., Rakuten Medical Inc., Merus N.V.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-hnc-global-market-report
How Is Head And Neck Cancer (HNC) Market Demand Varying Across Different Regions?
North America was the largest region in the head and neck cancer (HNC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer (HNC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Head And Neck Cancer (HNC) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=20825&type=smp
Browse Through More Reports Similar to the Global Head And Neck Cancer (HNC) Market 2025, By The Business Research Company
Hepatocellular Carcinoma Drugs Global Market Report 2025
Unresectable Hepatocellular Carcinoma Global Market Report 2025
Merkel Cell Carcinoma Treatment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model